Call for Abstract

17th International Conference on Metabolomics & Systems Biology, will be organized around the theme “”

Eurometabolomics-2021 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Eurometabolomics-2021

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Metabolomics is the large-scale study of small molecules, commonly known as metabolites, within cells, biofluids, tissues or organisms. Collectively, these small molecules and their interactions within a biological system are known as the metabolome.

At present, metabolomics is applied to investigate several human diseases, to improve their diagnosis and prevention, and to design better therapeutic strategies. In addition, metabolomic studies are also being carried out in areas such as toxicology and pharmacology, crop breeding, and plant biotechnology.

 

The two most common analytical approaches for the generation of metabolomics data are nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). NMR is a spectroscopic technique based on the principle of energy absorption and re-emission of the atom nuclei due to variations in an external magnetic field.

 


Proteomics is the scientific discipline which studies and searches for proteins that are associated with the disease by means of their altered levels of sequence. Each level of protein structure is essential to the finished molecule’s function. The focus of proteomics is a biological group called proteome (set of protein sequence).



 


NMR-based metabolomics provides a means to categorize organ-specific toxicity, monitor the onset and progression of toxicological effects, and identify biomarkers of toxicity. A future challenge, however, is to describe the cellular metabolome for purposes of understanding cellular functions

 

Systems biology is an approach in biomedical research to understanding the larger picture be it at the level of the organism, tissue, or cell—by putting its pieces together. It's in stark contrast to decades of reductionist biology, which involves taking the pieces apart.

 

Mass spectrometry-based metabolomics offers quantitative analyses with high selectivity and sensitivity and the potential to identify metabolites.

 

The primary aim of "omic" technologies is the nontargeted identification of all gene products (transcripts, proteins, and metabolites) present in a specific biological sample. ... Thus, metabolomics is a key technology for systems biology

 

Pharmacometabolomics is a branch of metabolomics, the disciple that quantifies and analyzes the metabolites existing in a biological sample

 

Metabolomics cancer research is being used to discover diagnostic cancer biomarkers in the clinic and in a research institute, to a better understand its complex heterogeneous nature, to discover pathways which involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide evidence to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate aims of most metabolomics cancer studies are to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient. Untargeted metabolomics is an important and excellent tool for probing cancer-altered biochemical pathways.